Results 91 to 100 of about 43,668 (144)

Development and Qualification of a VSV-N IgG ELISA to Assess Vector-Directed Humoral Immunity in VSV-Vectored Vaccine Studies. [PDF]

Vaccines (Basel)
Ayorinde M, Streatfield C, Kakarla V, Sigei F, Bromell R, Marini A, Zaric M.   +6 more
europepmc   +1 more source

A High-Potency Bovine Consensus Interferon Delivered by an Oral <i>Lactococcus lactis</i> System Exhibits Antiviral Activity Against VSV and BEV. [PDF]

Animals (Basel)
Zhao H, Li R, Yang Y, Ma Y, Jiang Y, Li J, Cui W, Qiao X.   +7 more
europepmc   +1 more source

Oncolytic virus-delivered GSDME: Unlocking pyroptosis to improve dendritic cell function and amplify cytotoxic T cell response. [PDF]

Mol Ther Oncol
Schneider S, Schwaiger T, Kröll J, Basbas I, Martin F, Xin D, Podgorschek E, Arnkil I, Glatz M, Mayr M, Petersson M, Scheidl S, Schneeberger S, Das K, Spiesschaert B, Mandl C, Carotta S, Knobbe-Thomsen CB, Elbers K, Nolden T.   +19 more
europepmc   +1 more source

Glycosphingolipids are essential entry factors for non-influenza orthomyxoviruses. [PDF]

J Gen Virol
Lozano-Montalbá L, Denis Z, Courgnaud V, Moreno-García J, Majzoub K, Sanjuán R, Dufloo J.   +6 more
europepmc   +1 more source

PAWR augments anti-RNA viral innate immunity by promoting the PIM2-XBP1s-RIG-I signaling axis. [PDF]

Nat Commun
Hou P, Sun X, Zhu H, Feng Y, Li R, Wang X, Zhang F, Wang J, Han Y, He DC, Wang H, He H.   +11 more
europepmc   +1 more source

Engagement of the TCR against an oncolytic virus generates a population of effector CAR T cells with potent antitumor activity. [PDF]

Sci Adv
Liseth O, Appleton E, Kendall B, Thompson J, Sangsuwannukul T, Tonne J, Diaz RM, Evgin L, Patrikeev A, Sarbia N, Foo S, Harrington K, Ono M, Melcher A, Vile R.   +14 more
europepmc   +1 more source

RNA-Binding Protein RBM25 Targets the mRNA Stability of GTPase Rab22a to Restrict Viral Entry and Infection. [PDF]

Adv Sci (Weinh)
Ding Y, Chen H, Jiang Y, Zhao C, Bai J, Xiang Y, Wang Z, Wang X, Rui B, Tang W, Ding Y, Zhan Z, Zhang Y, Liu X.   +13 more
europepmc   +1 more source

Repurposing screens reveal a role for PKCη and NF1 in SARS-CoV-2 infection. [PDF]

PLoS Pathog
Acuña JA, Miller J, Bhutda S, Ayyanathan K, Kamalia B, Whig K, Nguyen D, Zhu Y, Laleu B, Wells T, Samby K, Pekosz A, Schultz DC, Cherry S.   +13 more
europepmc   +1 more source

Targeted cleavage site mutations in the Gn precursor enable efficient generation of replication-competent rVSV-based surrogates for emerging nairoviruses. [PDF]

Emerg Microbes Infect
Jain S, Marot S, Karaaslan E, Sajadi MM, Baykam N, Yapar D, Shoemaker T, Montgomery JM, Spiropoulou CF, Albariño CG, Bergeron É.   +10 more
europepmc   +1 more source